Blincyto's label has gradually been extended since 2014, and in December the MHRA approved it as the first immunotherapy for ...

BMS' Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.

Shares of Amgen Inc. AMGN advanced 1.24% to $297.93 Thursday, on what proved to be an all-around dismal trading session for ...

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Cancer diagnoses tended to arise more in patients who bled on oral anticoagulants (OACs), a Canadian population-based cohort ...

During a live event, Alexander I. Spira, MD, PhD, and participants NGS testing practices and the rationale behind their ...

Amgen's AMGN short percent of float has risen 11.27% since its last report. The company recently reported that it has 12.74 million shares sold short, which is 2.37% of all regular shares that are ...

President Donald Trump said Tuesday that he will likely impose tariffs of 25% or more on imports of cars, semiconductors and pharmaceutical products. Speaking to reporters at his Mar-a-Lago club in ...

On February 13, 2025, the FDA approved Samsung Bioepis Co., Ltd.’s denosumab biosimilars, OSPOMYV™ (denosumab-dssb; 60 mg pre-filled syringe) ...